development -- one to Eli Lilly ( LLY ), one to the Drugs for Neglected Diseases initiative, or DNDi, and one to GlaxoSmithKline ( GSK ). See the Anacor website for more information. Article Scope This article's scope is somewhat limited since I am not a pharmacologist
also has good exposure to the emerging markets is [TICKER: GSK ] GlaxoSmithKline. They've run into some challenges in China ..... lot of the other really important emerging markets. [TICKER: GSK ] GlaxoSmithKline is well entrenched in the respiratory disease
LONDON, Dec 11 (Reuters) - GlaxoSmithKline is to invest another 200 million pounds ($330 million) on advanced manufacturing in Britain, the company said on Wednesday, underlining the draw of a tax break designed to encourage research and development.
Dec 6 (Reuters) - GlaxoSmithKline and Theravance Inc said on Friday that their combination therapy met the main goal of improving lung function in asthma patients in a late-stage trial.
profile of its probable future blockbuster cancer drug, "Palbociclib," Pfizer ( PFE ) collaborated with GlaxoSmithKline ( GSK ) . The company will evaluate Palbociclib in combination with GlaxoSmithKline's MEK inhibitor "Mekinist," also known as
Dec 5 (Reuters) - * GSK launches global consortium with six renowned cancer
Dec 5 (Reuters) - GSK * GSK press release: Synflorix receives European marketing authorisation for
campaign has now officially passed, visiting UK Prime Minister David Cameron has become a vocal supporter of GlaxoSmithKline ( GSK ), the British drugmaker that was at the center of one of the biggest attacks against a multinational during the summertime
SHANGHAI (Reuters) - British Prime Minister David Cameron on Tuesday mounted a robust defense of GlaxoSmithKline's business practices in China - where it is being investigated for alleged bribery - calling the firm "very decent".
SHANGHAI, Dec 3 (Reuters) - British Prime Minister David Cameron on Tuesday mounted a robust defence of GlaxoSmithKline's business practices in China - where it is being investigated for alleged bribery - calling the firm "very decent".